Immunovia

Immunovia AB was founded in 2007 by researchers from the Department of Immunotechnology at Lund University and CREATE Health (Center for Translational Cancer Research) in Lund, Sweden.Our strategy is to decipher the wealth of information in blood and transform it into clinically useful tools for diagnosing complex diseases such as cancer and autoimmune disorders earlier and more accurately than ever before.Immunovia's unique technology platform — IMMray™ — is an antibody-based multiplex test designed to provide a snapshot of the immune system's response based on the information available in a single drop of blood.